Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Orion clarifies information emanating from Capital Markets Day 12/4/2009 Stock exchange release 100,000 Orion A-shares converted into B-shares 11/27/2009 Stock exchange release Orion Group Interim Report January-September 2009 10/26/2009 Stock exchange release Orion Corporation's publication schedules for financial reporting in 2010 10/26/2009 Stock exchange release Orion withdraws US application for extending the indication of Stalevo® 10/21/2009 Stock exchange release Orion invites analysts and media to Q3 news conference on Monday 26 October 2009 10/6/2009 Stock exchange release Composition of the Nomination Committee of Orion Corporation 9/21/2009 Stock exchange release Orion and Hospira,Inc. sue Sandoz companies in the U.S. to enforce their U.S. Patents covering the proprietary drug Precedex® 9/4/2009 Stock exchange release Orion: Correction to English version of Interim Report 1-6/2009 8/7/2009 Stock exchange release Orion Group Interim Report January-June 2009 8/7/2009 Stock exchange release Orion comments on ANDA filed by Sandoz Inc. for a generic version of Orion's proprietary drug Precedex® (dexmedetomidine hydrochloride 100 mcg base/ml ) in the United States 7/31/2009 Stock exchange release Reijo Salonen receives the title of Professor 6/15/2009 Press release Orion invites analysts and media to Q2 news conference on Friday 7 August 2009 6/10/2009 Stock exchange release Orion reacquires rights for i.v. levosimendan (Simdax®) 5/6/2009 Stock exchange release Orion and Wockhardt settle patent dispute 4/29/2009 Stock exchange release Orion Group Interim Report 1-3/2009 4/27/2009 Stock exchange release Orion invites to a Q1 news conference on Monday 27 April 2009 4/20/2009 Stock exchange release Amendments to Orion's Articles of Association entered in the Trade Register 4/14/2009 Stock exchange release
